Cambridge Healthtech Institute:Inaugural Inherited Disease Diagnostics

The ability to sequence individual genomes has the potential to transform medicine and offer immense benefits to patients, clinicians, and researchers. Cambridge Healthtech Institute's Inaugural Inherited Disease Diagnostics will examine the state of the field, from prenatal and newborn screening to adult testing, and look at technologies for detecting gene mutations connected with rare and common diseases.
Adoption hurdles such as clinical utility, cost economics and regulatory oversight will be discussed. This event will focus on practical considerations for widespread implementation and solutions for continued advancement in disease diagnostics.
Who should attend: Vice Presidents, Directors, Managers, CEOs, CSOs, Professors and Scientists from Pharma, Biotechs and Academia working in fields such as genetics, healthcare, pathology, molecular biology, personalized and translational medicine, and pediatrics